☆ 4.3 Letter

MYH7 p.Glu903Gln Is a Pathogenic Variant Associated With Hypertrophic Cardiomyopathy

CIRCULATION-GENOMIC AND PRECISION MEDICINE (2021)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy

Neal K. Lakdawala et al.

Summary: In hypertrophic cardiomyopathy, women are diagnosed at an older age and more likely to have pathogenic genetic variants, partly influenced by genetic substrate. Women have a higher risk of developing severe heart failure symptoms and mortality.

CIRCULATION-GENOMIC AND PRECISION MEDICINE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical Utility of a Phenotype-Enhanced MYH7-Specific Variant Classification Framework in Hypertrophic Cardiomyopathy Genetic Testing

Connor L. Mattivi et al.

CIRCULATION-GENOMIC AND PRECISION MEDICINE (2020)

Add to Collection

Article Genetics & Heredity

Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel

Melissa A. Kelly et al.

GENETICS IN MEDICINE (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)

Perry M. Elliott et al.

EUROPEAN HEART JOURNAL (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Bernard J. Gersh et al.

CIRCULATION (2011)

Add to Collection

MYH7 p.Glu903Gln Is a Pathogenic Variant Associated With Hypertrophic Cardiomyopathy

Related references

Associations Between Female Sex, Sarcomere Variants, and Clinical Outcomes in Hypertrophic Cardiomyopathy

Clinical Utility of a Phenotype-Enhanced MYH7-Specific Variant Classification Framework in Hypertrophic Cardiomyopathy Genetic Testing

Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen's Inherited Cardiomyopathy Expert Panel

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)

2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Export Citation

Share Paper